Julie Rytlewski

4.5k total citations
33 papers, 910 citations indexed

About

Julie Rytlewski is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Julie Rytlewski has authored 33 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 17 papers in Immunology and 8 papers in Hematology. Recurrent topics in Julie Rytlewski's work include CAR-T cell therapy research (20 papers), Immunotherapy and Immune Responses (11 papers) and Multiple Myeloma Research and Treatments (8 papers). Julie Rytlewski is often cited by papers focused on CAR-T cell therapy research (20 papers), Immunotherapy and Immune Responses (11 papers) and Multiple Myeloma Research and Treatments (8 papers). Julie Rytlewski collaborates with scholars based in United States, France and Spain. Julie Rytlewski's co-authors include Erik Yusko, Harlan Robins, Slobodan Beronja, Eric R. Lutz, Daniel A. Laheru, Mark Yarchoan, Dung T. Le, Elizabeth M. Jaffee, Alexander C. Hopkins and Jennifer N. Durham and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Julie Rytlewski

33 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Rytlewski United States 13 579 307 291 119 117 33 910
Jens Wanzeck United States 6 518 0.9× 370 1.2× 396 1.4× 76 0.6× 139 1.2× 7 1.0k
Hin Ching Lo United States 4 560 1.0× 299 1.0× 271 0.9× 158 1.3× 231 2.0× 7 855
Melania Tesio France 15 469 0.8× 438 1.4× 529 1.8× 61 0.5× 120 1.0× 24 1.3k
Jessica Tsui United States 9 343 0.6× 491 1.6× 333 1.1× 187 1.6× 105 0.9× 15 987
Bärbel Schmitt Germany 12 396 0.7× 255 0.8× 276 0.9× 55 0.5× 71 0.6× 17 865
Hafsa Munir United Kingdom 11 445 0.8× 399 1.3× 313 1.1× 91 0.8× 132 1.1× 16 939
Dai-Chen Wu United States 5 562 1.0× 374 1.2× 502 1.7× 58 0.5× 120 1.0× 6 992
Minlong Shi China 7 200 0.3× 209 0.7× 549 1.9× 131 1.1× 104 0.9× 7 1.1k
Hiromi Sakashita Japan 17 427 0.7× 348 1.1× 322 1.1× 69 0.6× 189 1.6× 25 1.1k
Donald Wong United States 16 731 1.3× 553 1.8× 316 1.1× 107 0.9× 102 0.9× 28 1.1k

Countries citing papers authored by Julie Rytlewski

Since Specialization
Citations

This map shows the geographic impact of Julie Rytlewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Rytlewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Rytlewski more than expected).

Fields of papers citing papers by Julie Rytlewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Rytlewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Rytlewski. The network helps show where Julie Rytlewski may publish in the future.

Co-authorship network of co-authors of Julie Rytlewski

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Rytlewski. A scholar is included among the top collaborators of Julie Rytlewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Rytlewski. Julie Rytlewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paiva, Bruno, Irene Manrique, Julie Rytlewski, et al.. (2023). Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel. Blood Cancer Discovery. 4(5). 365–373. 11 indexed citations
2.
3.
4.
Schroeder, Brett, Bonnie LaFleur, Rachel Gittelman, et al.. (2021). CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes. Journal for ImmunoTherapy of Cancer. 9(8). e002812–e002812. 25 indexed citations
5.
Johnson, Sarah, et al.. (2021). Impact of HLA type, age and chronic viral infection on peripheral T-cell receptor sharing between unrelated individuals. PLoS ONE. 16(8). e0249484–e0249484. 8 indexed citations
6.
7.
Rytlewski, Julie, James S. Wilmott, Martín C. Mihm, et al.. (2020). Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nature Cancer. 1(2). 197–209. 19 indexed citations
8.
Rytlewski, Julie, Deepu Madduri, Timothy Campbell, et al.. (2020). Effects of Prior Alkylating Therapies on Preinfusion Patient Characteristics and Starting Material for CAR T Cell Product Manufacturing in Late-Line Multiple Myeloma. Blood. 136(Supplement 1). 7–8. 9 indexed citations
9.
Rytlewski, Julie, Shibing Deng, Tao Xie, et al.. (2019). Model to improve specificity for identification of clinically-relevant expanded T cells in peripheral blood. PLoS ONE. 14(3). e0213684–e0213684. 23 indexed citations
10.
Agdashian, David, Mei ElGindi, Changqing Xie, et al.. (2019). The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma. Cancer Immunology Immunotherapy. 68(4). 599–608. 103 indexed citations
11.
12.
Hopkins, Alexander C., Mark Yarchoan, Jennifer N. Durham, et al.. (2018). T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma. JCI Insight. 3(13). 175 indexed citations
13.
Tarhini, Ahmad A., Yan Lin, Lin Huang, et al.. (2018). Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire. Journal for ImmunoTherapy of Cancer. 6(1). 112–112. 51 indexed citations
14.
Arrieta‐Bolaños, Esteban, Pietro Crivello, Julie Rytlewski, et al.. (2018). Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing. Frontiers in Immunology. 9. 280–280. 7 indexed citations
15.
Prins, Robert M., Aaron Mochizuki, Joey Orpilla, et al.. (2018). ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL. Neuro-Oncology. 20(suppl_6). vi3–vi3. 1 indexed citations
16.
Brown, Jessie, Yoshiya Yonekubo, Nicole Hanson, et al.. (2017). TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma. Cell stem cell. 21(5). 650–664.e8. 125 indexed citations
17.
Brown, Samara, Cristiana M. Pineda, Tianchi Xin, et al.. (2017). Correction of aberrant growth preserves tissue homeostasis. Nature. 548(7667). 334–337. 107 indexed citations
18.
Rytlewski, Julie, et al.. (2015). Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs. Microvascular Research. 99. 26–35. 14 indexed citations
19.
Chung, Eunna, et al.. (2015). Fibrin-based 3D matrices induce angiogenic behavior of adipose-derived stem cells. Acta Biomaterialia. 17. 78–88. 73 indexed citations
20.
Rytlewski, Julie, et al.. (2012). Three-Dimensional Image Quantification as a New Morphometry Method for Tissue Engineering. Tissue Engineering Part C Methods. 18(7). 507–516. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Wanzeck Breakdown of academic impact, for papers by Hin Ching Lo Breakdown of academic impact, for papers by Melania Tesio Breakdown of academic impact, for papers by Jessica Tsui Breakdown of academic impact, for papers by Bärbel Schmitt Breakdown of academic impact, for papers by Hafsa Munir Breakdown of academic impact, for papers by Dai-Chen Wu Breakdown of academic impact, for papers by Minlong Shi Breakdown of academic impact, for papers by Hiromi Sakashita Breakdown of academic impact, for papers by Donald Wong
Rankless by CCL
2026